Viewing Study NCT01490866


Ignite Creation Date: 2025-12-24 @ 4:24 PM
Ignite Modification Date: 2025-12-28 @ 6:28 PM
Study NCT ID: NCT01490866
Status: COMPLETED
Last Update Posted: 2019-09-24
First Post: 2011-11-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
Sponsor: SCRI Development Innovations, LLC
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: SCRI GI 154
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View